Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Non Operating Income (2018 - 2020)

Sonoma Pharmaceuticals has reported Non Operating Income over the past 7 years, most recently at $234000.0 for Q1 2020.

  • For Q1 2020, Non Operating Income rose 73.33% year-over-year to $234000.0; the TTM value through Mar 2020 reached $276000.0, down 17.37%, while the annual FY2025 figure was -$548000.0, 376.77% down from the prior year.
  • Non Operating Income for Q1 2020 was $234000.0 at Sonoma Pharmaceuticals, up from -$134000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $234000.0 in Q1 2020 and troughed at -$134000.0 in Q4 2019.
  • A 4-year average of $67857.1 and a median of $41000.0 in 2019 define the central range for Non Operating Income.
  • Biggest five-year swings in Non Operating Income: tumbled 709.09% in 2019 and later surged 73.33% in 2020.
  • Year by year, Non Operating Income stood at -$31000.0 in 2016, then surged by 170.97% to $22000.0 in 2018, then tumbled by 709.09% to -$134000.0 in 2019, then skyrocketed by 274.63% to $234000.0 in 2020.
  • Business Quant data shows Non Operating Income for SNOA at $234000.0 in Q1 2020, -$134000.0 in Q4 2019, and $41000.0 in Q3 2019.